Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
CathWorks FFRangio System employs drug-free, wire-free technology for comprehensive physiological assessment.
Tag Archives: M&A
Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
Exclusive agreement expands Medtronic’s comprehensive pain interventions portfolio, increases treatment options for patients living with chronic pain.
Agilent to Acquire Biocare Medical Clinical and Research Pathology Solutions
Agilent says the acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth through customer-centric innovation and disciplined capital allocation.
Agilent says the acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth through customer-centric innovation and disciplined capital allocation.
RadNet Acquires Gleamer to Support Position as a Radiology Clinical AI Solutions Leader
RadNet leadership says the acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth through customer-centric innovation and disciplined capital allocation.
Thermo Fisher Scientific to Acquire Purification and Filtration Business
Solventum purification and filtration portfolio expected to be highly complementary with Thermo Fisher’s bioproduction business, strengthening the company in the high growth bioprocessing market.
Teleflex announces plan to separate its businesses
Teleflex to create a new, independent publicly traded company consisting of its Urology, Acute Care, and OEM businesses. Remaining units and recently announced acquisition expected to remain.
Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc.
Acquisition to expand cardiovascular portfolio with complementary and differentiated calcium modification platform, furthering company’s strategy to address coronary and peripheral disease.
Stryker enters peripheral vascular segment with Inari Medical acquisition
Acquisition expected to strengthen Stryker’s neurovascular business with Inari VTE product portfolio including mechanical thrombectomy solutions for peripheral vascular diseases such as deep vein thrombosis and pulmonary embolism.
4 Red Flags Investors Look For When Vetting Your Medical Device Company
Experts point out some pitfalls that medtech companies should be aware of when trying to raise capital.
Biopharma and Medical Device Trends Investors Should Watch in 2022
For private equity and venture capital investors alike, there are five key trends presenting both headwinds and tailwinds that may impact investment flows into 2022.